|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Amylin>> Market Analysis Reports |
Market Analysis Reports of Amylin |
|
Amylin Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in ... Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H2 2018 ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... understanding Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma ... Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2018 ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... understanding Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma ... Global Market Report of AMYLIN (1-13) (HUMAN) (CAS 198328-30-2) December 2024 Global Market Report of AMYLIN (8-37) (RAT) (CAS 138398-61-5) December 2024 Global Market Report of AMYLIN (8-37) (HUMAN) (CAS 135702-23-7) December 2024 Global Market Report of AMYLIN, HUMAN (CAS 122384-88-7) December 2024 Amylin Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis Amylin Pharmaceuticals, Inc. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results. Islet Amyloid Polypeptide - Pipeline Review, H2 2020 ... muscle. Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... understanding Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma ... Islet Amyloid Polypeptide - Pipeline Review, H1 2020 ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... understanding Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma ... Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... understanding Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma ... Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021 ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... involved in Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or ... understanding Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma ... Diabetes Drug Market, Oral (DPP IV Inhibitor, SGLT-2, Alpha Glucosidase Inhibitor, Biguanide) Injection (Glucagon-like peptide (GLP) 1 agonist, Amylin Receptor Agonist), Insulin (Rapid – Acting Insulin, Long Acting Insulin, Premixed Insulin), Regions (United States, Europe, Japan, China, India, Brazil), Companies (Novo Nordisk, Merck & Co, Eli Lilly, AstraZeneca, Johnson & Johnson, Boehringer Ingelheim) ... Glucagon-like peptide (GLP) 1 agonist, Amylin Receptor Agonist), Insulin (Rapid – Acting ... like peptide (GLP) 1 agonist and Amylin receptor agonist market. Insulin ... Glucagon-like peptide (GLP) 1 agonist 2. Amylin receptor agonist Insulin 1. Rapid – Acting ... Alkermes, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... The company is collaborating with Amylin Pharmaceuticals, Inc. (Amylin) on the development of a once weekly ... of type 2 diabetes. BYDUREON is an injectable formulation of Amylins BYETTA (exenatide) and is being developed ... Takeda Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... differs from antidepressants. In November 2009, Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical ... agreement includes products to be developed from Amylin's pipeline, including pramlintide/metreleptin and ... Alexandria Real Estate Equities Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... of Technology, Theravance, Inc., Genentech, Inc., Amylin Pharmaceuticals, Inc., Amgen, Inc., and ... Eli Lilly & Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... . The company co-promotes Byetta with Amylin Pharmaceuticals, Inc. in the United States ... Orexigen Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , Inc., GlaxoSmithKline, Arena Pharmaceuticals, Inc., Amylin Pharmaceuticals, Inc., Alizyme plc, Athersys ... Global Exenatide Injection Supply, Demand and Key Producers, 2023-2029 ... as a part of this study include AstraZeneca, Amylin, Baxter Pharmaceutical, Lilly and Chenfei ... Clinic Pharmacy Companies Profiled: AstraZeneca Amylin Baxter Pharmaceutical Lilly Chenfei Pharmaceutical ... Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Glucagon Like Peptide-1 (GLP-1) Agonists Market 2018, Forecast to 2023 ... GSK Sanofi Bristol-Myers Squibb Amylin Market Segment by Regions, regional analysis ... |